4.6 Review

Metastatic Progression of Osteosarcomas: A Review of Current Knowledge of Environmental versus Oncogenic Drivers

Related references

Note: Only part of the references are listed.
Article Cell Biology

Suspension state and shear stress enhance breast tumor cells EMT through YAP by microRNA-29b

Boyuan Zhao et al.

Summary: This study discovers the mechanism that Sus and SS promote BTCs EMT by YAP through miR-29b posttranscriptionally.

CELL BIOLOGY AND TOXICOLOGY (2023)

Article Oncology

Treatment of 120 adult osteosarcoma patients with metachronous and synchronous metastases: A retrospective series of the French Sarcoma Group

Elise Lavit et al.

Summary: Treatment options for metastatic osteosarcomas are limited, and surgical removal of metastases is crucial for patient prognosis. Patients who relapse often receive multiple lines of systemic therapy and may be enrolled in clinical trials if available.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Multidisciplinary Sciences

Fat1 deletion promotes hybrid EMT state, tumour stemness and metastasis

Ievgenia Pastushenko et al.

Summary: This study reveals that mutation of the FAT1 gene promotes tumor initiation, progression, invasiveness, stemness, and metastasis. Loss of function of FAT1 activates a CAMK2-CD44-SRC axis while inactivates EZH2, playing important roles in the expression of YAP1 and ZEB1.

NATURE (2021)

Article Oncology

The lncRNA NEAT1 promotes the epithelial-mesenchymal transition and metastasis of osteosarcoma cells by sponging miR-483 to upregulate STAT3 expression

Yan Chen et al.

Summary: Research has shown that the NEAT1/miR-483/STAT3 axis plays an important role in regulating the metastasis of osteosarcoma. Potential therapeutic targeting of this axis could have beneficial effects on osteosarcoma treatment in the future.

CANCER CELL INTERNATIONAL (2021)

Article Oncology

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

Kjetil Boye et al.

Summary: This study aimed to evaluate the activity and safety of the PD-1 antibody pembrolizumab in adult patients with advanced osteosarcoma. The results showed that pembrolizumab was well-tolerated but did not demonstrate clinically significant antitumor activity in the patients. Further trials with immunomodulatory agents in osteosarcoma should explore combination strategies in patients selected based on molecular profiles associated with response.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Review Pharmacology & Pharmacy

Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma

Zhi Xiong Chong et al.

Summary: Osteosarcoma, a prevalent primary bone tumor, has high metastatic potential and poor prognosis. MiRNAs play crucial roles in regulating the EMT process in osteosarcoma, which may offer insights for prognostic and therapeutic strategies.

PHARMACOLOGICAL RESEARCH (2021)

Review Biochemistry & Molecular Biology

YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming

Giorgia Di Benedetto et al.

Summary: Cellular reprogramming involves converting specialized cells into another type or inducing pluripotent stem cells, requiring modifications in the epigenetic asset and gene regulatory networks. The process involves a metabolic rearrangement similar to tumorigenesis and relies on a network of signaling pathways with a crucial role played by components of the Hippo pathway, YAP and TAZ.

METABOLITES (2021)

Review Oncology

A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression

Hong-Li Li et al.

Summary: The Hippo pathway can promote tumor invasion and metastasis by regulating the expression of target genes. YAP/TAZ, as the core molecules of the Hippo pathway, interact with TEADs to regulate the expression of target genes related to tumor metastasis and invasion. Target genes induced by YAP/TAZ can lead to invasive pseudopodia formation, reduced intercellular adhesion, ECM degradation, EMT, or indirectly promote invasion and metastasis through other signaling pathways.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)

Article Oncology

lncRNA-CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway

Hongqi Wang et al.

Summary: The study revealed that CASC15 is highly expressed in OS patients and cell lines, promoting cell proliferation and migration while affecting the cell cycle through the activation of the Wnt/beta-catenin pathway. Overexpression of CASC15 in OS cells led to increased metastasis both in vivo and in vitro, with a direct impact on the Wnt pathway and subsequent epithelial-mesenchymal transition.

ONCOLOGY REPORTS (2021)

Article Orthopedics

Skip metastases in high-grade intramedullary appendicular osteosarcoma: an indicator of more aggressive disease?

Asif Saifuddin et al.

Summary: The presence of skip metastases in high-grade appendicular osteosarcoma may indicate a more aggressive disease, as it is significantly associated with both lung and skeletal metastases, as well as poorer survival outcomes.

SKELETAL RADIOLOGY (2021)

Review Oncology

Systematic Review of Recurrent Osteosarcoma Systemic Therapy

Ioanna Gazouli et al.

Summary: Osteosarcoma is the most common primary bone cancer predominantly affecting young individuals. Despite the improved chances of cure with surgery and cytotoxic chemotherapy, recurrent and refractory disease remains a significant therapeutic challenge. A systematic review of available clinical evidence on the treatment of recurrent and/or refractory osteosarcoma in the past two decades found that most treatments failed to elicit objective responses, with no identified driver mutations as effective treatment targets or predictive biomarkers for treatment effectiveness. Continued clinical and preclinical research is needed to uncover the biological mechanisms of recurrent and refractory osteosarcoma and expand therapeutic options for pre-treated patients.

CANCERS (2021)

Article Oncology

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?

Eric Thebault et al.

Summary: This study describes the first and subsequent relapses in osteosarcoma patients, and proposes the design recommendations for randomized phase-II trials, including broad inclusion criteria and PFS as the primary endpoint.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Role of MicroRNAs in Human Osteosarcoma: Future Perspectives

Lola Llobat et al.

Summary: Osteosarcoma is a rare but highly deadly cancer, especially among children and adolescents. The discovery of miRNAs holds potential for earlier diagnosis, prognosis prediction, and development of new therapies for various types of tumors, including OS. The number of clinical trials involving miRNAs as prognostic and diagnostic biomarkers, as well as therapeutic targets, is likely to increase in the near future.

BIOMEDICINES (2021)

Review Biochemistry & Molecular Biology

Intercellular communication through extracellular vesicles in cancer and evolutionary biology

Scott E. Bonner et al.

Summary: Extracellular vesicles (EVs) are nano-sized membrane enclosed vesicles released by cells and have been recognized as important mediators of intercellular communication. In cancer, tumor-derived EVs can influence metastatic behavior, establish favorable microenvironments, and support cancer development and progression.

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2021)

Article Immunology

A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children

Feng Jiang et al.

Summary: A four-gene signature related to hypoxia in osteosarcoma was developed and validated to predict recovery and serve as an independent prognostic predictor, representing overall immune response strength in the tumor microenvironment of pediatric patients with osteosarcoma.

JOURNAL OF IMMUNOLOGY RESEARCH (2021)

Article Oncology

Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma

Kang-Wen Xiao et al.

Summary: In this study, a novel macrophage-associated risk score was developed to differentiate between low- and high-risk groups of osteosarcoma patients. The high-risk group showed worse prognosis, while the low-risk group had higher immune and stromal scores. The risk score was identified as an independent prognostic factor for osteosarcoma.

JOURNAL OF ONCOLOGY (2021)

Article Oncology

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma

Yun Liu et al.

Summary: This study identified different cellular subtypes and key transcription factors associated with survival prognosis in osteosarcoma (OS) through single-cell RNA sequencing. Moreover, it revealed the mechanisms by which osteoblastic OS cells regulate osteolysis and angiogenesis, impacting survival prognosis. Furthermore, the study highlighted the potential of immunotherapy targeting CD8(+) T cells and macrophages for OS treatment.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

A Novel Six Metastasis-Related Prognostic Gene Signature for Patients With Osteosarcoma

Di Zheng et al.

Summary: The study identified 6 metastasis-related genes and constructed a novel prognostic signature for predicting overall survival in osteosarcoma patients, with FHIT potentially being a therapeutic target.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

Delay in diagnosis of primary osteosarcoma of bone in children: Have we improved in the last 15 years and what is the impact of delay on diagnosis?

Shinichirou Yoshida et al.

Summary: The study revealed an improvement in the length of symptoms of children with osteosarcoma over the last 15 years, with a correlation between delay in diagnosis and presence of metastases at presentation, and an impact of delay in diagnosis on prognosis.

JOURNAL OF BONE ONCOLOGY (2021)

Article Oncology

Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes

Wei Qi et al.

Summary: Autophagy-related genes were identified as pivotal prognostic signatures for osteosarcoma patients, and a risk score model based on 14 autophagy-related genes effectively predicted patient prognosis, guiding clinical decision making in treatment.

PATHOLOGY & ONCOLOGY RESEARCH (2021)

Article Biochemistry & Molecular Biology

Rab22a-NeoF1 fusion protein promotes osteosarcoma lung metastasis through its secretion into exosomes

Li Zhong et al.

Summary: The study revealed that the Rab22a-NeoF1 fusion protein in osteosarcoma promotes the formation of pulmonary pre-metastatic niche by exosomes and subsequently enhances lung metastasis. Additionally, exosomal PYK2 activates signaling pathways in recipient macrophages and osteosarcoma cells, leading to an increase in the M2 phenotype.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Cell Biology

An update on the roles of circular RNAs in osteosarcoma

Zheng Li et al.

Summary: Osteosarcoma, the most common primary bone malignancy, is believed to arise from bone-forming mesenchymal stem cells, with aberrant activation of oncogenes and inactivation of tumor suppressor genes playing a key role in its pathogenesis. In addition to protein-coding genes, non-coding RNAs, especially circRNAs, have been found to be crucial in the initiation and progression of osteosarcoma. CircRNAs, single-stranded RNAs that form covalently closed loops, function as important regulatory elements of the genome and have been shown to play critical roles in osteosarcoma progression.

CELL PROLIFERATION (2021)

Article Biochemistry & Molecular Biology

A risk signature-based on metastasis-associated genes to predict survival of patients with osteosarcoma

Yi Shi et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2020)

Article Oncology

Prognostic impact of diagnostic and treatment delays in children with osteosarcoma

Liliana Vasquez et al.

PEDIATRIC BLOOD & CANCER (2020)

Review Biochemistry & Molecular Biology

Autophagy regulation by microRNAs: Novel insights into osteosarcoma therapy

Zeinab Jamali et al.

IUBMB LIFE (2020)

Review Cell Biology

The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis

Heinrich Kovar et al.

CELLS (2020)

Article Biochemistry & Molecular Biology

Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming

Alekhya Mazumdar et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, General & Internal

Very late relapse of high-grade osteosarcoma A case report and review of the literature

Yoichi Kaneuchi et al.

MEDICINE (2020)

Review Oncology

BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer

Nisansala Chandimali et al.

ONCOLOGY LETTERS (2020)

Article Multidisciplinary Sciences

Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy

Charles P. Couturier et al.

NATURE COMMUNICATIONS (2020)

Review Biochemistry & Molecular Biology

Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma

N. E. Kushlinskii et al.

MOLECULAR BIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients

Jun Wang et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Article Orthopedics

Survival of osteosarcoma patients following diagnosis of synchronous skip metastases

Peiming Yang et al.

JOURNAL OF ORTHOPAEDICS (2020)

Review Cell Biology

Noncoding RNAs as circulating biomarkers in osteosarcoma patients

Gerardo Botti et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Review Medicine, Research & Experimental

The Roles of Circular RNAs in Osteosarcoma

Yong Zhang et al.

MEDICAL SCIENCE MONITOR (2019)

Article Oncology

Genetic and clonal dissection of osteosarcoma progression and lung metastasis

Huaiyuan Xu et al.

INTERNATIONAL JOURNAL OF CANCER (2018)

Review Pharmacology & Pharmacy

Paving the Rho in cancer metastasis: Rho GTPases and beyond

Sepp Jansen et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Multidisciplinary Sciences

Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis

Mariana Pavel et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Clonal dynamics in osteosarcoma defined by RGB marking

Stefano Gambera et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, Research & Experimental

Calpain-6 controls the fate of sarcoma stem cells by promoting autophagy and preventing senescence

Caroline Andrique et al.

JCI INSIGHT (2018)

Letter Pharmacology & Pharmacy

Increased PD-L1 expression in breast and colon cancer stem cells

Yanheng Wu et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)

Review Oncology

Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors

Mauricio Rodriguez-Torres et al.

CLINICAL & EXPERIMENTAL METASTASIS (2016)

Article Orthopedics

Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?

Todd E. Bertrand et al.

CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2016)

Article Oncology

Adjuvant Immunotherapy to Improve Outcome in High-Risk Pediatric Sarcomas

Melinda S. Merchant et al.

CLINICAL CANCER RESEARCH (2016)

Article Medicine, Research & Experimental

Deciphering signaling networks in osteosarcoma pathobiology

Christos Adamopoulos et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2016)

Review Oncology

Metastatic osteosarcoma: a challenging multidisciplinary treatment

Cristina Meazza et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2016)

Review Medical Laboratory Technology

MicroRNAs in osteosarcoma

Jian Zhang et al.

CLINICA CHIMICA ACTA (2015)

Article Oncology

Immunotherapeutic Approaches to Sarcoma

Melissa Burgess et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2015)

Article Biotechnology & Applied Microbiology

miR-382 Inhibits Osteosarcoma Metastasis and Relapse by Targeting Y Box-Binding Protein 1

Meng Xu et al.

MOLECULAR THERAPY (2015)

Article Multidisciplinary Sciences

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

Devon A. Lawson et al.

NATURE (2015)

Review Immunology

Immune cell promotion of metastasis

Takanori Kitamura et al.

NATURE REVIEWS IMMUNOLOGY (2015)

Review Developmental Biology

The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease

Xaralabos Varelas

DEVELOPMENT (2014)

Article Multidisciplinary Sciences

CD271+ Osteosarcoma Cells Display Stem-Like Properties

Jiguang Tian et al.

PLOS ONE (2014)

Review Oncology

Molecular mechanisms of chemoresistance in osteosarcoma

Hongtao He et al.

ONCOLOGY LETTERS (2014)

Article Oncology

Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma

Allison Marion et al.

INTERNATIONAL JOURNAL OF CANCER (2012)

Article Pathology

Multicentric Osteosarcoma Clinicopathologic and Radiographic Study of 56 Cases

Domenico Corradi et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)

Article Oncology

A clinico-morphological study of 95 cases of sarcomas with metastases to the lungs

N. Krishnamoorthy et al.

INDIAN JOURNAL OF CANCER (2011)

Review Oncology

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

Nikolas H. Stoecklein et al.

INTERNATIONAL JOURNAL OF CANCER (2010)

Article Oncology

Late Recurrence in Pediatric Cancer: A Report From the Childhood Cancer Survivor Study

Karen Wasilewski-Masker et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)

Article Oncology

Parallel progression of primary tumours and metastases

Christoph A. Klein

NATURE REVIEWS CANCER (2009)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Editorial Material Cell & Tissue Engineering

Epithelial-mesenchymal transition and the stem cell phenotype

Derek C. Radisky et al.

CELL STEM CELL (2008)

Article Oncology

Late relapse of osteosarcoma: Implications for follow-up and screening

SJ Strauss et al.

PEDIATRIC BLOOD & CANCER (2004)